Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genetic Tech Spn Ads (GENE)

Genetic Tech Spn Ads (GENE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,678
  • Shares Outstanding, K 15,028
  • Annual Sales, $ 10 K
  • Annual Income, $ -4,100 K
  • 60-Month Beta 2.53
  • Price/Sales 9,210.02
  • Price/Cash Flow N/A
  • Price/Book 4.55
Trade GENE with:

Options Overview

Details
  • Implied Volatility 152.83%
  • Historical Volatility 63.10%
  • IV Percentile 33%
  • IV Rank 30.32%
  • IV High 283.15% on 12/09/20
  • IV Low 96.12% on 03/24/21
  • Put/Call Vol Ratio 0.15
  • Today's Volume 6,771
  • Volume Avg (30-Day) 658
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 7,197
  • Open Int (30-Day) 4,872

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.85 +18.70%
on 03/25/21
5.74 -20.38%
on 04/09/21
+0.28 (+6.53%)
since 03/09/21
3-Month
3.58 +27.65%
on 03/05/21
8.18 -44.13%
on 01/21/21
+0.47 (+11.46%)
since 01/08/21
52-Week
1.55 +194.84%
on 04/15/20
10.30 -55.63%
on 07/15/20
+2.88 (+169.89%)
since 04/09/20

Most Recent Stories

More News
Genetic Technologies Provides Update on COVID-19 Risk Test Launch

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health business provides an update to the market on the progress of the US commercial...

GENE : 4.57 (+6.53%)
Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI-driven preventative health business is pleased to announce a co-exclusive production and distribution...

GENE : 4.57 (+6.53%)
Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report(R)

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the "Company"), a leader in the development of genetic risk assessment tests, today announced an interview with Dr. George Muchnicki, Chief Medical...

GENE : 4.57 (+6.53%)
Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the "Company"), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced registered direct...

GENE : 4.57 (+6.53%)
Genetic Technologies Announces $6.56 Million Registered Direct Offering

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the "Company"), a leader in the development of genetic risk assessment tests, today announced that it has entered into definitive agreements with...

GENE : 4.57 (+6.53%)
Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company"), provides the following update to the market on further development on the COVID-19 serious disease risk Polygenic...

GENE : 4.57 (+6.53%)
Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX

Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the 'Company'), announced today that they have entered into a three-year partnership agreement with mental health company,...

GENE : 4.57 (+6.53%)
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company") is pleased to announce an interview with its interim-CEO, Dr. Jerzy Muchnicki aired on The RedChip Money Report...

GENE : 4.57 (+6.53%)
Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company") is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share insight into the company's recent...

GENE : 4.57 (+6.53%)
Genetic Technologies Provides Update on COVID-19 Risk Test

Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, "Company"), provides the following update to the market on the development of the Company's COVID-19 Risk Test.

GENE : 4.57 (+6.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across...

See More

Key Turning Points

3rd Resistance Point 6.97
2nd Resistance Point 6.36
1st Resistance Point 5.46
Last Price 4.57
1st Support Level 3.95
2nd Support Level 3.34
3rd Support Level 2.44

See More

52-Week High 10.30
Fibonacci 61.8% 6.96
Fibonacci 50% 5.93
Fibonacci 38.2% 4.89
Last Price 4.57
52-Week Low 1.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar